These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 20634195)
1. Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disorders. Zhou X; Nie Z; Roberts A; Zhang D; Sebat J; Malhotra D; Kelsoe JR; Geyer MA Hum Mol Genet; 2010 Oct; 19(19):3797-805. PubMed ID: 20634195 [TBL] [Abstract][Full Text] [Related]
2. Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia. Ji B; Wang X; Pinto-Duarte A; Kim M; Caldwell S; Young JW; Behrens MM; Sejnowski TJ; Geyer MA; Zhou X PLoS One; 2013; 8(6):e66327. PubMed ID: 23823008 [TBL] [Abstract][Full Text] [Related]
3. GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders. Young JW; Kamenski ME; Higa KK; Light GA; Geyer MA; Zhou X Neuropsychopharmacology; 2015 Nov; 40(12):2715-26. PubMed ID: 25907107 [TBL] [Abstract][Full Text] [Related]
4. Transcription factor SP4 is a susceptibility gene for bipolar disorder. Zhou X; Tang W; Greenwood TA; Guo S; He L; Geyer MA; Kelsoe JR PLoS One; 2009; 4(4):e5196. PubMed ID: 19401786 [TBL] [Abstract][Full Text] [Related]
5. Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice. Higa KK; Ji B; Buell MR; Risbrough VB; Powell SB; Young JW; Geyer MA; Zhou X Int J Neuropsychopharmacol; 2015 Jun; 18(11):pyv063. PubMed ID: 26037489 [TBL] [Abstract][Full Text] [Related]
6. Ketamine independently modulated power and phase-coupling of theta oscillations in Sp4 hypomorphic mice. Wang X; Pinto-Duarte A; Behrens MM; Zhou X; Sejnowski TJ PLoS One; 2018; 13(3):e0193446. PubMed ID: 29513708 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization. Zhou X; Long JM; Geyer MA; Masliah E; Kelsoe JR; Wynshaw-Boris A; Chien KR Mol Psychiatry; 2005 Apr; 10(4):393-406. PubMed ID: 15558077 [TBL] [Abstract][Full Text] [Related]
8. Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning. Sun X; Pinacho R; Saia G; Punko D; Meana JJ; Ramos B; Gill G Dev Neurobiol; 2015 Jan; 75(1):93-108. PubMed ID: 25045015 [TBL] [Abstract][Full Text] [Related]
9. Over-representation of potential SP4 target genes within schizophrenia-risk genes. Zhou X Mol Psychiatry; 2022 Feb; 27(2):849-854. PubMed ID: 34750502 [TBL] [Abstract][Full Text] [Related]
10. Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Zhou X; Qyang Y; Kelsoe JR; Masliah E; Geyer MA Genes Brain Behav; 2007 Apr; 6(3):269-76. PubMed ID: 16899055 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes. Fujioka R; Nii T; Iwaki A; Shibata A; Ito I; Kitaichi K; Nomura M; Hattori S; Takao K; Miyakawa T; Fukumaki Y Mol Brain; 2014 Apr; 7():31. PubMed ID: 24758191 [TBL] [Abstract][Full Text] [Related]
12. Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia. Pinacho R; Valdizán EM; Pilar-Cuellar F; Prades R; Tarragó T; Haro JM; Ferrer I; Ramos B J Psychiatr Res; 2014 Nov; 58():189-96. PubMed ID: 25175639 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the transcription factor Sp4 is reduced by NMDA receptor signaling. Saia G; Lalonde J; Sun X; Ramos B; Gill G J Neurochem; 2014 May; 129(4):743-52. PubMed ID: 24475768 [TBL] [Abstract][Full Text] [Related]
15. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649 [TBL] [Abstract][Full Text] [Related]
16. A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability. Konen LM; Wright AL; Royle GA; Morris GP; Lau BK; Seow PW; Zinn R; Milham LT; Vaughan CW; Vissel B Mol Brain; 2020 Feb; 13(1):27. PubMed ID: 32102661 [TBL] [Abstract][Full Text] [Related]
17. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain. Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341 [TBL] [Abstract][Full Text] [Related]
18. Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors. Rosenberg N; Gerber U; Ster J J Neurosci; 2016 Nov; 36(45):11521-11531. PubMed ID: 27911756 [TBL] [Abstract][Full Text] [Related]
19. Brain-specific Crmp2 deletion leads to neuronal development deficits and behavioural impairments in mice. Zhang H; Kang E; Wang Y; Yang C; Yu H; Wang Q; Chen Z; Zhang C; Christian KM; Song H; Ming GL; Xu Z Nat Commun; 2016 Jun; 7():. PubMed ID: 27249678 [TBL] [Abstract][Full Text] [Related]